What does the IRA really achieve when it comes to prescription medications? What are its effects on independent pharmacies, the 340B program, or even DIR fees? What parts of the equation are missing, and what inclusions would make the IRA better for everyone?
Listen in as PUTTcast hosts Monique Whitney and Lauren Young take a deep dive into the answers to these questions and many more with special guest American Pharmacies General Counsel, Miguel Rodriguez.
Version: 20241125
1 years ago
So instead of making sure that no one in any country gets unfairly charged way more than the other countries people they’ve put a temporary seeming fix to the problem that the pharmaceutical companies are already crying foul about and you say something to the effect that it Hass to be fixed this problem exactly how is that going to impact the people this is supposed to be protecting in America who are already paying more than they can afford for literally everything they buy in America?!